Advertisement
Advertisement
FMS
Fresenius Medical Care AG
22.55
USDSponsored
+0.05
+0.20%
Oct 28, 15:20 UTC -4
Open
Fresenius Medical Care AG (FMS) Earnings
FMS Earnings Reports
Positive Surprise Ratio
FMS beat 28 of 43 last estimates.
65%
Next Report
Next Week
Date of Next Report
Nov 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$4.95B
/$1.03
Implied change from Q2 26 (Revenue/ EPS)
+1.89%
/-8.04%
Implied change from Q3 25 (Revenue/ EPS)
+1.39%
/-6.36%
Fresenius Medical Care AG earnings per share and revenue
On Aug 03, 2026, FMS reported earnings of 1.12 USD per share (EPS) for Q2 26, beating the estimate of 1.05 USD, resulting in a 7.22% surprise. Revenue reached 4.86 billion, compared to an expected 4.84 billion, with a 0.39% difference. The market reacted with a -4.95% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 3 analysts forecast an EPS of 1.03 USD, with revenue projected to reach 4.95 billion USD, implying an decrease of -8.04% EPS, and increase of 1.89% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Intuitive Surgical Inc.
Report Date
Oct 20, 2026 For Q3 26
Estimate
$2.69
Actual
$3.00
Surprise
+11.29%
IQVIA Holdings Inc.
Report Date
Oct 27, 2026 For Q3 26
Estimate
$3.30
Actual
$3.34
Surprise
+0.97%
Thermo Fisher Scientific, Inc.
Report Date
Oct 21, 2026 For Q3 26
Estimate
$6.46
Actual
$6.68
Surprise
+3.29%
Axogen, Inc. Common Stock
Report Date
Oct 28, 2026 For Q3 26
Estimate
$0.14
Actual
$0.21
Surprise
+47.06%
Integra LifeSciences Holdings
Report Date
Oct 21, 2026 For Q3 26
Estimate
$0.57
Actual
$0.59
Surprise
+3.04%
Beta Bionics, Inc. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.53
Actual
-$0.52
Surprise
+2.73%
OrthoPediatrics Corp. Common Stock
Report Date
Oct 27, 2026 For Q3 26
Estimate
-$0.21
Actual
-$0.23
Surprise
-4.88%
FAQ
What were Fresenius Medical Care AG's earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, Fresenius Medical Care AG reported EPS of $1.12, beating estimates by 7.22%, and revenue of $4.86B, 0.39% above expectations.
How did the market react to Fresenius Medical Care AG's Q2 2026 earnings?
The stock price moved down -4.95%, changed from $25.26 before the earnings release to $24.01 the day after.
When is Fresenius Medical Care AG expected to report next?
The next earning report is scheduled for Nov 03, 2026.
What are the forecasts for Fresenius Medical Care AG's next earnings report?
Based on 3
analysts, Fresenius Medical Care AG is expected to report EPS of $1.03 and revenue of $4.95B for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.